Home > Insider Trading > Filing (0001144204-14-064137)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1410098	Cormedix Inc.	CRMD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189703	M Cora Tellez	C/O Cormedix Inc. 745 Route 202-206, Suite 303 Bridgewater NJ US 08807		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value Per Share	Acquisiton	2014-10-17	2,100	$1.55	2,300	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock, $0.001 Par Value Per Share	Stock Option (right to buy)	$2.05		2024-04-03	30,000	30,000	Direct
Common Stock, $0.001 Par Value Per Share	Series C-3 Non-voting Convertible Preferred Sotck	$1.00			50,000	5,000	Direct
Common Stock, $0.001 Par Value Per Share	Common Stock Warrants (right to buy)	$0.90	2014-01-08	2020-01-08	25,000	25,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2024-04-03	30,000	30,000	Direct
	50,000	5,000	Direct
2020-01-08	25,000	25,000	Direct

Footnotes

The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.548 to $1.55.
These shares vest 1/3 on date of grant, 1/3 on first anniversary of date of grant and 1/3 on second anniversary of date of grant.
On January 8, 2014, the reporting person acquired through a private placement, (i) 5,000 shares of the Company's Series C-3 Non-Voting Convertible Preferred Stock, each share convertible into 10 shares of Common Stock, $0.001 par value per share; and (ii) a five-year warrant to purchase common Stock at an exercise price of $1.25 per share. The Series C-3 Non-voting Convertible Preferred Stock and warrants were purchased together at a purchase price of $10.00 per share. The warrant exercise price was decreased to $0.90 per share effective September 15, 2014.